Status:
RECRUITING
Anatomical-Clinical Base of Adenocarcinoma Pancreatic
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Adenocarcinoma
Carcinoma
Eligibility:
All Genders
18-120 years
Brief Summary
BACAP-2 is a prospective biobank dedicated to the pancreatic adenocarcinoma including clinical data and biological samples from tumor. The aim is to enrich the previous propective collection BACAP in ...
Detailed Description
Pancreatic cancer represents the fourth cause of death by cancer in Western countries. In over 90% of cases, it is due to an adenocarcinoma. The only curative treatment for pancreatic cancer remains t...
Eligibility Criteria
Inclusion
- Patient with pancreatic mass syndrome explored by ultrasound endoscopy with cytopuncture or
- Patient with pancreatic mass syndrome explored by an abdominal scanner with and without injection of product contrast and/or puncture of the mass or secondary lesions by radiological route or
- Patient with pancreatic adenocarcinoma proven histologically and/or cytologically
Exclusion
- Patient with a pancreatic tumor whose analysis histological is not an adenocarcinoma
- Pregnant or breastfeeding patient
Key Trial Info
Start Date :
November 16 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 28 2035
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT06128343
Start Date
November 16 2023
End Date
February 28 2035
Last Update
February 3 2025
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Béthune hospital center
Béthune, France, 62408
2
Haut-Lévêque Hospital
Bordeaux, France, 33604
3
Huriez Hospital
Lille, France, 59037
4
Jean Mermoz private hosptila
Lyon, France, 69008